Free Trial
NASDAQ:SGRY

Surgery Partners Q3 2025 Earnings Report

Surgery Partners logo
$20.59 -0.54 (-2.56%)
Closing price 04:00 PM Eastern
Extended Trading
$20.58 0.00 (-0.02%)
As of 04:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Surgery Partners EPS Results

Actual EPS
N/A
Consensus EPS
$0.19
Beat/Miss
N/A
One Year Ago EPS
N/A

Surgery Partners Revenue Results

Actual Revenue
N/A
Expected Revenue
$823.55 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Surgery Partners Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Tuesday, November 11, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

Surgery Partners Earnings Headlines

Trump's Law S.1582: $21T Dollar Revolution Coming
Do you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. If you do…tc pixel
See More Surgery Partners Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Surgery Partners? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surgery Partners and other key companies, straight to your email.

About Surgery Partners

Surgery Partners (NASDAQ:SGRY) operates as a healthcare services provider specializing in the management and ownership of ambulatory surgery centers, surgical hospitals and multispecialty rehabilitation hospitals across the United States. Through its network of facilities, the company coordinates and delivers a broad range of outpatient surgical procedures in specialties such as orthopedics, ophthalmology, otolaryngology, gastroenterology, pain management and general surgery. Its integrated platform offers ancillary services including on-site imaging, laboratory testing, infusion therapy and physical, occupational and speech rehabilitation.

Since its establishment in 2010 and subsequent public listing in 2015, Surgery Partners has focused on strategic partnerships with physicians and health systems to expand access to cost-effective outpatient care. The company deploys a capital-light management services model as well as joint-venture ownership structures to develop and acquire facilities in mid-sized and underserved markets. As of the most recent disclosures, Surgery Partners maintains operations in more than 25 states, serving patients through over 200 ambulatory surgery centers and multiple inpatient surgical and rehabilitation hospitals.

Headquartered in Nashville, Tennessee, Surgery Partners emphasizes clinical governance and regulatory compliance, leveraging standardized protocols to drive quality outcomes and operational efficiency. The leadership team is led by President and Chief Executive Officer Douglas Coltharp, who brings extensive experience in healthcare strategy, capital markets and operations. Under Coltharp’s guidance, the company continues to pursue selective growth opportunities while maintaining collaborative relationships with physician partners and payors to address the evolving demands of value-based care.

View Surgery Partners Profile

More Earnings Resources from MarketBeat